Search results
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 6 days agoIn October 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
Bristol-Myers Squibb Expected to Earn Q2 2024 Earnings of $1.76 Per Share (NYSE:BMY)
ETF DAILY NEWS· 14 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2024 EPS estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 4 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News via Yahoo News· 5 days agoMissouri Sen. Josh Hawley is pushing to expand payments to those exposed to Manhattan Project...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News· 5 days agoThe Radiation Exposure Compensation Act has been a lifeline for some people and families exposed to...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 5 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Bristol-Myers Squibb (NYSE:BMY) Releases Earnings Results, Beats Expectations By $0.13 EPS
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($4.40) EPS for the quarter, beating the consensus ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 1 day agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
Bristol-Myers Squibb (NYSE:BMY) Forecasted to Post Q3 2024 Earnings of $1.67 Per Share
ETF DAILY NEWS· 4 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Analysts at Zacks Research cut their Q3 2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday ...
Sigma Planning Corp Decreases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 6 days agoSigma Planning Corp lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 65.9% during the 4th quarter, according to the company in its most recent filing with the ...